Applied DNA Appoints Stephen Birkhold to the Strategic Advisory Board
January 29 2019 - 5:00AM
Business Wire
Branding Expert Will Help Deploy a Proven
Textile Integrity Platform to the Fashion World
Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA,”
“the Company”), a leader in PCR-based DNA manufacturing for product
authenticity and traceability solutions, announced today the
appointment of Stephen Birkhold to the Company’s Strategic Advisory
Board (“SAB”) and retention as a consultant to assist the Company
with market penetration in the fashion and luxury apparel and
accessory markets.
Mr. Birkhold is a 30-year veteran of the fashion industry and is
the former CEO of several of the world’s most prominent apparel
brands. He has a proven record of effective strategic management,
leading globally recognized brands, and having served as the CEO of
Bebe Stores, Lacoste, Diesel and Earl Jeans, along with a 10-year
tenure at VF Corporation working with Lee Jeans and Nautica
Jeans.
Dr. James Hayward, President and CEO of Applied DNA, said,
“Steve Birkhold is one of the most respected names in fashion. His
expertise will help us bridge the strategic connection between our
leading-edge technology and the supply chains and associated claims
of contemporary fashion. His knowledge of the global business
environment within the fashion world, and his entrée in the most
recognized C-suites, will accelerate our go-to-market
timeline.”
Wayne Buchen, Vice President of Strategic Sales for Textiles at
Applied DNA Sciences, added, “Steve’s expertise in fashion
merchandising includes marketing, retail, wholesale, e-commerce and
strategic positioning in a very competitive, fast-moving vertical
that is a perfect fit for our technical platform. Together, we will
help global brands to secure their position with forensic
science.”
Under the terms of Mr. Birkhold’s consulting agreement, Mr.
Birkhold will spearhead the development of a new sales, marketing
and go-to-market strategy for the Company’s technology in the
fashion and luxury apparel and accessory markets. Mr. Birkhold will
leverage his substantial industry contacts to facilitate the
introduction of the Company’s technology to the C-suite executives
of well-known fashion and luxury apparel and accessory brands.
“By understanding a fashion brand’s business challenges, Applied
DNA is uniquely qualified to secure their claims of sustainability,
relevance to the circular economy, ethical sourcing and the
veracity of fiber content,” said Mr. Birkhold. “I am delighted to
join their world-class team, and to offer contemporary brands the
tools to improve global trade in fashion.”
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and DNA mass production for
diagnostics, personalized medicine and therapeutics.
Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion.
Visit adnas.com for more information. Follow us
on Twitter and LinkedIn. Join our mailing
list.
Common stock listed on NASDAQ under the symbol APDN, and
warrants are listed under the symbol APDNW.
Forward-Looking Statements
The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe Applied DNA’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
Applied DNA. Actual results could differ materially from those
projected due to its history of net losses, limited financial
resources, limited market acceptance and various other factors
detailed from time to time in Applied DNA’s SEC reports and
filings, including our Annual Report on Form 10-K filed on December
18, 2018 and other reports we file with the SEC, which are
available at www.sec.gov. Applied DNA undertakes no obligation
to update publicly any forward-looking statements to reflect new
information, events or circumstances after the date hereof to
reflect the occurrence of unanticipated events, unless otherwise
required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190129005269/en/
investors: Sanjay Hurry, 212-838-3777,
shurry@lhai.commedia: Meryl Rader, 781-639-4924,
meryl@cgprpublicrelations.comprogram:
MeiLin Wan, 631-240-8849,
meilin.wan@adnas.comweb: www.adnas.comtwitter:
@apdn
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024